Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis.

Amin NB, Carvajal-Gonzalez S, Purkal J, Zhu T, Crowley C, Perez S, Chidsey K, Kim AM, Goodwin B.

Sci Transl Med. 2019 Nov 27;11(520). pii: eaav9701. doi: 10.1126/scitranslmed.aav9701.

PMID:
31776293
2.
3.

Blood pressure-lowering effect of the sodium glucose co-transporter-2 inhibitor ertugliflozin, assessed via ambulatory blood pressure monitoring in patients with type 2 diabetes and hypertension.

Amin NB, Wang X, Mitchell JR, Lee DS, Nucci G, Rusnak JM.

Diabetes Obes Metab. 2015 Aug;17(8):805-8. doi: 10.1111/dom.12486. Epub 2015 Jun 17.

PMID:
25951755
4.

Two dose-ranging studies with PF-04937319, a systemic partial activator of glucokinase, as add-on therapy to metformin in adults with type 2 diabetes.

Amin NB, Aggarwal N, Pall D, Paragh G, Denney WS, Le V, Riggs M, Calle RA.

Diabetes Obes Metab. 2015 Aug;17(8):751-9. doi: 10.1111/dom.12474. Epub 2015 May 11.

PMID:
25885172
5.

Dose-ranging efficacy and safety study of ertugliflozin, a sodium-glucose co-transporter 2 inhibitor, in patients with type 2 diabetes on a background of metformin.

Amin NB, Wang X, Jain SM, Lee DS, Nucci G, Rusnak JM.

Diabetes Obes Metab. 2015 Jun;17(6):591-598. doi: 10.1111/dom.12460. Epub 2015 Mar 31.

PMID:
25754396
6.

Metabolites in safety testing assessment in early clinical development: a case study with a glucokinase activator.

Sharma R, Litchfield J, Atkinson K, Eng H, Amin NB, Denney WS, Pettersen JC, Goosen TC, Di L, Lee E, Pfefferkorn JA, Dalvie DK, Kalgutkar AS.

Drug Metab Dispos. 2014 Nov;42(11):1926-39. doi: 10.1124/dmd.114.060087. Epub 2014 Aug 20.

PMID:
25142735
7.

Influence of i.v. haloperidol on ventricular repolarization and monophasic action potential duration in anesthetized dogs.

Rasty S, Amin NB, Sabbah HN, Mishima T, Borzak S, Tisdale JE.

Chest. 2004 May;125(5):1821-9.

PMID:
15136396
8.

Characterization of gentamicin pharmacokinetics in patients hemodialyzed with high-flux polysulfone membranes.

Amin NB, Padhi ID, Touchette MA, Patel RV, Dunfee TP, Anandan JV.

Am J Kidney Dis. 1999 Aug;34(2):222-7.

PMID:
10430966
9.

Dialysate iron therapy: infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis.

Gupta A, Amin NB, Besarab A, Vogel SE, Divine GW, Yee J, Anandan JV.

Kidney Int. 1999 May;55(5):1891-8.

10.

Sinus bradycardia and multiple episodes of sinus arrest following administration of ibutilide.

Amin NB, Borzak S, Housholder S, Tisdale JE.

Heart. 1998 Jun;79(6):628-9. No abstract available.

11.

Atrial fibrillation after bypass surgery: does the arrhythmia or the characteristics of the patients prolong hospital stay?

Borzak S, Tisdale JE, Amin NB, Goldberg AD, Frank D, Padhi ID, Higgins RS.

Chest. 1998 Jun;113(6):1489-91.

PMID:
9631782
12.

Cyclosporine levels impact early rejection episodes.

Granger DK, Amin NB, Sorenson AL, Gillingham KJ, Canafax DM, Matas AJ.

Transplant Proc. 1994 Oct;26(5):2513. No abstract available.

PMID:
7940771

Supplemental Content

Support Center